Protalix BioTherapeutics, Inc. Share Price
PLXProtalix BioTherapeutics, Inc. Stock Performance
Open $1.92 | Prev. Close $1.91 | Circuit Range N/A |
Day Range $1.91 - $2.02 | Year Range $1.32 - $3.19 | Volume 32,966 |
Average Traded $1.97 |
Protalix BioTherapeutics, Inc. Share Price Chart
About Protalix BioTherapeutics, Inc.
Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Protalix BioTherapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $1.92 | $2.02 | +0.00% |
20-May-26 | $1.92 | $2.02 | +5.48% |
18-May-26 | $2.04 | $1.92 | -2.79% |
15-May-26 | $1.99 | $1.97 | -1.75% |
14-May-26 | $1.94 | $2.00 | +3.08% |
13-May-26 | $1.98 | $1.95 | +2.37% |
12-May-26 | $1.94 | $1.90 | -1.55% |
FAQs on Protalix BioTherapeutics, Inc. Share Price
Can I buy Protalix BioTherapeutics, Inc. shares in India?
What is the share price of Protalix BioTherapeutics, Inc.?
What is the 5 year returns of Protalix BioTherapeutics, Inc.?
What are the high & low stock price of Protalix BioTherapeutics, Inc. today?
What is the 52-week high and low of Protalix BioTherapeutics, Inc. stock?